Literature DB >> 26562129

Cascade of Care for Hepatitis C Virus Infection Within the US Veterans Health Administration.

Marissa M Maier1, David B Ross1, Maggie Chartier1, Pamela S Belperio1, Lisa I Backus1.   

Abstract

OBJECTIVES: We measured the quality of HCV care using a cascade of HCV care model.
METHODS: We estimated the number of patients diagnosed with chronic HCV, linked to HCV care, treated with HCV antivirals, and having achieved a sustained virologic response (SVR) in the electronic medical record data from the Veterans Health Administration's Corporate Data Warehouse and the HCV Clinical Case Registry in 2013.
RESULTS: Of the estimated 233,898 patients with chronic HCV, 77% (181,168) were diagnosed, 69% (160,794) were linked to HCV care, 17% (39,388) were treated with HCV antivirals, and 7% (15,983) had achieved SVR.
CONCLUSIONS: This Cascade of HCV Care provides a clinically relevant model to measure the quality of HCV care within a health care system and to compare HCV care across health systems.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26562129      PMCID: PMC4815568          DOI: 10.2105/AJPH.2015.302927

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  17 in total

1.  Hepatitis C virus screening and prevalence among US veterans in Department of Veterans Affairs care.

Authors:  Lisa I Backus; Pamela S Belperio; Timothy P Loomis; Gale H Yip; Larry A Mole
Journal:  JAMA Intern Med       Date:  2013-09-09       Impact factor: 21.873

2.  A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

Authors:  Lisa I Backus; Derek B Boothroyd; Barbara R Phillips; Pamela Belperio; James Halloran; Larry A Mole
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-11       Impact factor: 11.382

3.  Hepatitis C in the United States.

Authors:  Scott D Holmberg; Philip R Spradling; Anne C Moorman; Maxine M Denniston
Journal:  N Engl J Med       Date:  2013-05-16       Impact factor: 91.245

4.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2012-08-17

5.  Outcome of sustained virological responders with histologically advanced chronic hepatitis C.

Authors:  Timothy R Morgan; Marc G Ghany; Hae-Young Kim; Kristin K Snow; Mitchell L Shiffman; Jennifer L De Santo; William M Lee; Adrian M Di Bisceglie; Herbert L Bonkovsky; Jules L Dienstag; Chihiro Morishima; Karen L Lindsay; Anna S F Lok
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

6.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

7.  Clinical Case Registries: simultaneous local and national disease registries for population quality management.

Authors:  Lisa I Backus; Sergey Gavrilov; Timothy P Loomis; James P Halloran; Barbara R Phillips; Pamela S Belperio; Larry A Mole
Journal:  J Am Med Inform Assoc       Date:  2009-08-28       Impact factor: 4.497

8.  Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.

Authors:  Nezam Afdhal; Stefan Zeuzem; Paul Kwo; Mario Chojkier; Norman Gitlin; Massimo Puoti; Manuel Romero-Gomez; Jean-Pierre Zarski; Kosh Agarwal; Peter Buggisch; Graham R Foster; Norbert Bräu; Maria Buti; Ira M Jacobson; G Mani Subramanian; Xiao Ding; Hongmei Mo; Jenny C Yang; Phillip S Pang; William T Symonds; John G McHutchison; Andrew J Muir; Alessandra Mangia; Patrick Marcellin
Journal:  N Engl J Med       Date:  2014-04-11       Impact factor: 91.245

9.  Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010.

Authors:  Maxine M Denniston; Ruth B Jiles; Jan Drobeniuc; R Monina Klevens; John W Ward; Geraldine M McQuillan; Scott D Holmberg
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

10.  Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.

Authors:  Nezam Afdhal; K Rajender Reddy; David R Nelson; Eric Lawitz; Stuart C Gordon; Eugene Schiff; Ronald Nahass; Reem Ghalib; Norman Gitlin; Robert Herring; Jacob Lalezari; Ziad H Younes; Paul J Pockros; Adrian M Di Bisceglie; Sanjeev Arora; G Mani Subramanian; Yanni Zhu; Hadas Dvory-Sobol; Jenny C Yang; Phillip S Pang; William T Symonds; John G McHutchison; Andrew J Muir; Mark Sulkowski; Paul Kwo
Journal:  N Engl J Med       Date:  2014-04-11       Impact factor: 91.245

View more
  29 in total

1.  Achievement of hepatitis C cascade of care milestones: a population-level analysis in Alberta, Canada.

Authors:  Conar R O'Neil; Emily Buss; Sabrina Plitt; Mariam Osman; Carla S Coffin; Carmen L Charlton; Stephen Shafran
Journal:  Can J Public Health       Date:  2019-06-20

2.  Monitoring the hepatitis C care cascade using administrative claims data.

Authors:  Cheryl Isenhour; Susan Hariri; Claudia Vellozzi
Journal:  Am J Manag Care       Date:  2018-05       Impact factor: 2.229

3.  Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015-March 2018.

Authors:  Tengiz Tsertsvadze; Amiran Gamkrelidze; Nikoloz Chkhartishvili; Akaki Abutidze; Lali Sharvadze; Vakhtang Kerashvili; Maia Butsashvili; David Metreveli; Lia Gvinjilia; Shaun Shadaker; Muazzam Nasrullah; Ekaterine Adamia; Stefan Zeuzem; Nezam Afdhal; Sanjeev Arora; Karla Thornton; Beth Skaggs; Tinatin Kuchuloria; Maia Lagvilava; David Sergeenko; Francisco Averhoff
Journal:  Clin Infect Dis       Date:  2020-08-22       Impact factor: 9.079

4.  Hepatitis C cascade of care among people who inject drugs in Vancouver, Canada.

Authors:  Samantha Young; Evan Wood; M-J Milloy; Kora DeBeck; Sabina Dobrer; Ekaterina Nosova; Thomas Kerr; Kanna Hayashi PhD
Journal:  Subst Abus       Date:  2018-10-02       Impact factor: 3.716

5.  Engagement in the Hepatitis C Care Cascade Among Homeless Veterans, 2015.

Authors:  Amanda J Noska; Pamela S Belperio; Timothy P Loomis; Thomas P O'Toole; Lisa I Backus
Journal:  Public Health Rep       Date:  2017-01-30       Impact factor: 2.792

6.  A Surveillance-Based Hepatitis C Care Cascade, New York City, 2017.

Authors:  Miranda S Moore; Angelica Bocour; Fabienne Laraque; Ann Winters
Journal:  Public Health Rep       Date:  2018-06-14       Impact factor: 2.792

7.  Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.

Authors:  Marissa M Maier; Xiao-Hua Zhou; Michael Chapko; Steven L Leipertz; Xuan Wang; Lauren A Beste
Journal:  Dig Dis Sci       Date:  2018-02-16       Impact factor: 3.199

Review 8.  Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure.

Authors:  Meredith E Clement; Lauren F Collins; Julius M Wilder; Michael Mugavero; Taryn Barker; Susanna Naggie
Journal:  Infect Dis Clin North Am       Date:  2018-06       Impact factor: 5.982

9.  Racial/Ethnic Disparities in Follow-Up Adherence for Incidental Pulmonary Nodules: An Application of a Cascade-of-Care Framework.

Authors:  Rebecca A Schut; Eduardo J Mortani Barbosa
Journal:  J Am Coll Radiol       Date:  2020-08-07       Impact factor: 5.532

10.  Prevalence of Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus Among Homeless and Nonhomeless United States Veterans.

Authors:  Amanda J Noska; Pamela S Belperio; Timothy P Loomis; Thomas P O'Toole; Lisa I Backus
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.